Welcome to ECOL - Join Free - Sign In
API-Neomycin Sulfate
API-Neomycin Sulfate
Supplier Info
[China Supplier]
Contact Person : Ms. Wang Yolanda
Tel : 86-371-60273203
Fax : 86-371-60959778
Product Detail
1.API-Neomycin Sulfate 2.Veterinary drugs material 3. GMP Plant 4. Antibiotic 5. Leading manufacture OEM

API-Neomycin Sulfate

Properties: This product is a white powder; odorless; easy to absorb moisture; aqueous solution was right-handed light. This product is easily dissolved in water, ethanol, chloroform in Yimi or practically insoluble.

Purpose: to aminoglycoside antibiotics neomycin, against Staphylococcus aureus, diphtheria and anthrax, Gram-negative bacteria, positive bacteria and Mycobacterium tuberculosis has had better effect. The most sensitive to Escherichia coli, Staphylococcus aureus, the anthrax bacillus, Corynebacterium diphtheriae, gas Bacillus Proteus and Shigella flexneri, more sensitive, less sensitive to Pseudomonas aeruginosa. Bacteria of the goods and streptomycin, kanamycin, gentamicin may occur between the cross resistance

API-Neomycin Sulfate

Properties: This product is a white powder; odorless; easy to absorb moisture; aqueous solution was right-handed light. This product is easily dissolved in water, ethanol, chloroform in Yimi or practically insoluble.

Purpose: to aminoglycoside antibiotics neomycin, against Staphylococcus aureus, diphtheria and anthrax, Gram-negative bacteria, positive bacteria and Mycobacterium tuberculosis has had better effect. The most sensitive to Escherichia coli, Staphylococcus aureus, the anthrax bacillus, Corynebacterium diphtheriae, gas Bacillus Proteus and Shigella flexneri, more sensitive, less sensitive to Pseudomonas aeruginosa. Bacteria of the goods and streptomycin, kanamycin, gentamicin may occur between the cross resistance

API-Neomycin Sulfate

Related Products
Ads by Google

Hot Products: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | 0-9
Copyright Notice @ 2008-2022 ECOL Limited and/or its subsidiaries and licensors. All rights reserved.